Harry A. Quigley

Dr. HARRY A. QUIGLEY is the A. Edward Maumenee Professor of Ophthalmology and the director of the Glaucoma Center of Excellence at the Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for eight years as its Secretary, and was elected to five-year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and as editor-in-chief of Investigative Ophthalmology and Visual Science.

He has published over 350 peer-reviewed articles and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity, and progression rate of glaucoma and other eye disease in American, African, Asian, and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats, and mice.